MTOR and cancer: Initial studies using rapamycin to verify the involvement of mTOR signaling for tumorigenic formation of CSCs that were discussed previously provided a convincing basis that targeting the mTOR pathway using inhibitors may eradicate CSCs which can in turn augment overall cancer treatment.